Mr. Raphael, age 40, is a seasoned leader who brings more than 17 years of industry experience to his role at LabStyle including product delivery, technology and business development.

Prior to joining LabStyle in 2012, Mr. Raphael held a leadership position in portfolio business transformation at Nokia Siemens Networks, and prior to that held senior positions at Amdocs Limited (NYSE: DOX), ranging from leading large technology teams worldwide to a complex software development transformation that streamlined a change in the management and business operation of more than 1,500 employees worldwide.

25 years of financial and accounting experience, particularly with public and private medical device public companies.  Among his previous roles, he served as corporate vice president and Chief Financial Officer of Given Imaging Ltd., a medical diagnostic company (formerly NASDAQ:GIVN), where he was a part of the founding team and also helped lead the company’s growth from a start up to a $65 million annual revenue commercial enterprise as well as its successful initial and follow-on public offerings.  Following his tenure at Given, Mr. Ben-David served as Chief Financial Officer of Ultrashape Medical Ltd., where he led the company through two major rounds of funding totally $35 million to an initial public offering on the Tel Aviv Stock Exchange and ultimately its acquisition by Syneron Medical in 2012.   Recently, Ben-David has been an independent medical device entrepreneur and investor.

Mr. Bacher has more than 15 years of software business experience, including managing positions in product development at both mobile and semi-conductor companies. He brings profound software product strategy knowledge and a proven track record of transforming vision into operating products.

Prior to joining LabStyle Innovations, Mr. Bacher served in a leadership role at Amdocs Limited (NYSE : DOX) managing enterprise development programs for a variety of software products associated with BSS ,OSS and service delivery. Prior to Amdocs, he served in a senior role at Tower Semiconductor (NASDAQ : TSEM), in the CMOS image sensor division where he was responsible for high end as well as commodity product development.

Over 25 years of Medical Device Commercial and Technical leadership, most recently as the Vice President and General Manager of Neighborhood Diabetes, a division of Insulet focused on delivering Diabetic supplies through DME and pharmacy channels with a “high touch” training approach.  Prior he held a number of positions of increasing responsibility over 7 years at Smith & Nephew Orthopaedics, most recently as President, Asia Pacific, based in Sydney, Australia.

Mr. Durniak holds a BS of Engineering in Biomedical Engineering from the University of Vermont and an MBA from Boston University.

Mr. Raphael, age 40, is a seasoned leader who brings more than 17 years of industry experience to his role at LabStyle including product delivery, technology and business development.

Prior to joining LabStyle in 2012, Mr. Raphael held a leadership position in portfolio business transformation at Nokia Siemens Networks, and prior to that held senior positions at Amdocs Limited (NYSE: DOX), ranging from leading large technology teams worldwide to a complex software development transformation that streamlined a change in the management and business operation of more than 1,500 employees worldwide.

Hila Karah is an independent business consultant and an investor in several high-tech, bio-tech and Internet companies.  From 2006 to 2013, she served as a partner and Chief Investment Officer of Eurotrust Ltd., a Family office.  From 2002-2005, she served as a research analyst at Perceptive Life Sciences Ltd., a New York-based hedge fund.  Prior to that, Ms. Karah served as research analyst at Oracle Partners Ltd., a health care-focused hedge fund.  Ms. Karah served as a director in several private and public companies including Intec Pharma, since 2009 and Cyren Ltd since 2008. Ms. Karah holds a BA in molecular and cell Biology from the University of California, Berkeley, and studied at the University of California, Berkeley-University of California, San Francisco Joint Medical Program.

Prof. Stone brings over forty-five years of legal and business experience to LabStyle as an entrepreneur, venture capitalist, public company officer and director, and legal and corporate governance expert. He currently serves on the board of directors of multiple technology companies, including Powermat, Espro-Accoustiguide Group, Wellsense Technologies, NanoX Imaging and Check-Cap. Among his other public company experiences, Prof. Stone cofounded Lev Pharmaceuticals, Inc. which was sold to ViroPharma in 2008 for nearly $450 million in upfront consideration.

Prof. Stone is presently and has since 1974 served as a professor at Columbia Law School, specializing in tax law and business planning, and previously served as an Assistant Solicitor General of the United States. He also served as Chairman of the Conference of Presidents of Major American Jewish Organizations. He is a graduate of Harvard University and Harvard Law School.

Mr. McGrath joined LabStyle’s board of directors in November 2013. He currently serves as President, CFO and board director of PhotoMedex, Inc. (NasdaqGS: PHMD,) joining the company in 2000. He has earned honors as the 2012 SmartCEO Magazine CEO of the Year for Turnaround Companies as well as 2012 finalist for P.A.C.T. Investment Deal of the Year and 2013 finalist for Ernst & Young Entrepreneur of the Year.

Mr. McGrath has significant expertise in public and private fund raising, mergers and acquisitions, and manufacturing. He has held several senior-level positions in prior endeavors of public companies as well as the internet and e-commerce space, including AnswerThink Consulting Group, Think New Ideas, Inc. and triSpan, Inc. He is also currently a director of Noninvasive Medical Technologies, Inc. and serves on the Board of Advisors of Taylor University. Mr. McGrath graduated maxima cum laude with a B.S. in accounting from LaSalle University in 1979.

Since 1986, Dr. Hoenlein is the executive vice chairman of the Conference of Presidents of Major American Jewish Organizations, the coordinating body on international and national concerns for 52 national American Jewish organizations. Dr. Hoenlein has a B.A. in Political Science from Temple University and a Master’s Degree in International Relations from the University of Pennsylvania. Born in Philadelphia, Pennsylvania. Mr. Hoenlein has received two honoree doctorates. He is involved in several high tech and bio tech companies.

Rami Yehudiha, is a marketing and advertising executive with a particular expertise in developing and implementing campaigns utilizing cutting edge technologies and methods. From 2004 to the present, he has served as the Founder and Chief Executive Officer of LEAD, a top ten Israeli advertising firm. From 1997 to 2003, he served as the Chief Executive Officer at Ogilvy One Israel, a part of the WPP Group. Mr. Yehudiha received his B.A. in Political Science and Economics from Tel Aviv University and an M.B.A. in Marketing from Manchester University.

Professor Raz is a world-renowned diabetes specialist. He is a professor of Internal Medicine at Hadassah University Medical Center and the head of the Diabetes Unit and Research Center at Hadassah. He also serves as the head of the Israel National Council of Diabetes and as a member of several international editorial boards.

Professor Raz has published extensively in the area of diabetes, with over 190 publications to his credit. As president of the Israel Diabetes Research Group, he collaborates with other diabetes specialists in Israel and worldwide, conducting clinical research aimed at improving the treatment of diabetic patients. He is also the president of D-Cure, a non-profit foundation involving diabetes research. Professor Raz is currently leading several international clinical studies involving prevention of Type 1 Diabetes and protection of kidneys and hearts of diabetics.

Thirty years ago, as Dr. Rosman was beginning his career helping people with metabolic disorders, he saw how badly diabetes management approaches were failing patients. This has inspired him to spend most of his career researching and validating a new approach that could work for both doctors and patients.

When he met David Edelman, founder of Diabetes Daily, one of the largest online diabetes communities in 2010, he recognized an opportunity to test these ideas on a large scale. He helped build an online diabetes university and tested out the management theories with thousands of people living with diabetes. The results were transformative and confirmed his hypothesis, inspiring a journey to build tools to help everyone with diabetes to realize their dreams for healthy and meaningful lives.

Dr Rosman has served roles in industry, academia and non-profit leadership. He was Former Senior Medical Advisor at Eli Lilly & Company, has held teaching positions at Ohio University and Northeastern Ohio Universities College of Medicine, as well as served as President or Chair of American Diabetes Association, Ohio Chapter, American Association of Clinical Endocrinologists, Ohio River Chapter, and the Ohio Diabetes Prevention and Control Program at Ohio Department of Health.

Mr. Robert G. Faissal is a Managing Partner of Lebita Consulting Services LLC, a Toronto based business development and investment group with emphasis on commercial relationships in North America, Europe, Africa and the Middle East. Lebita Consulting focuses on healthcare, technology, finance, oil and gas and real estate. Mr Faissal was the Managing Partner of Richmond Development, an Abu Dhabi based multi-disciplinary investment group. From 1997 until 2000, Mr. Faissal served as the Managing Director/Middle East & Africa for the Philadelphia based Wharton Econometrics Forecasting Associates (WEFA Group, currently IHS Global Insight) advising various governments and private sector clients on economics and financial matters in the Middle East and Africa.

Mr. Robert G. Faissal holds a Master of Arts degree in Economics & International Finance from McMaster University in Canada and an undergraduate Honors Degree in Economics from the University of Western Ontario.

Erez Levy is currently the General Manager of the Global Direct Conversion Detector at GE Healthcare, Israel. Mr. Levy brings with him 18 years of strong and diverse leadership experience in the field of medical device design, process engineering, manufacturing and supply chain. Born in Haifa, Israel, Mr. Levy graduated from the Technion Institute of Technology with a B.Sc. degree in Industrial Engineering in Management in 1996. He then began working as Manufacturing Program Manager in the Missile Division of Rafael, Israel’s top developer of military technology. Mr. Levy began his career with GE Healthcare in 2000 as Material Site Manager in Haifa, Israel and received his Six Sigma Green Belt in 2001. In 2003, he became certified Lead Manufacturing Leader. In 2004 he relocated with his family to Cleveland, Ohio as an Operation Manger in GE Coils. Returning to Israel in 2006, he was appointed VCP Leader in Nuclear Medicine, engineering drive design for cost in NPI process.

During 2008-2010 Mr. Levy led the evaluation, due diligence and negotiation process of Orbotech acquisition by GE and became the integration manger after deal closing. In 2011 he was appointed as General Manager of Global Direct Conversion Detector, CZT solid-state Center of Excellence located in Rehovot, Israel. In his current role, Erez has full responsibility of technology, design, process development and operations excellence.  He drives innovation, quality management, product development initiatives, lead new technology market penetration and market share growth. Mr. Levy has completed his MBA studies at the Technion Institute of Technology in Haifa, Israel.

Gary Scheiner, CDE, MS has lived with type 1 diabetes since 1985 and was acknowledged as the 2014 Diabetes Educator of the Year by the American Association of Diabetes Educators. Known for his globally-available coaching services at IntegratedDiabetes.com, Scheiner has dedicated his professional life to improving the lives of people with insulin-dependent diabetes.

Scheiner has authored six books: You Can Control Diabetes (1997), Think Like A Pancreas (2004), The Ultimate Guide to Accurate Carb Counting (2007), Get Control of Your Blood Sugar (2009), Think Like A Pancreas, 2nd edition (2011), and Until There’s A Cure (2012).
Scheiner holds a BA in Psychology, an MS in Exercise Physiology, and is a Certified Diabetes Educator who trained at the Joslin Diabetes Center.

Dr. Polonsky is an internationally recognized expert in the behavioral aspects of diabetes management. He co-founded the Behavioral Diabetes Institute to advance research and develop effective programs to serve the often unrecognized emotional needs of people with diabetes. He is author of numerous books, including the famed Diabetes Burnout: What to Do When You Can’t Take It Anymore.

A licensed Clinical Psychologist and Certified Diabetes Educator, he has served as Senior Psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators. He has also served on the editorial boards of Diabetes Care, Diabetes Forecast, Clinical Diabetes, Diabetes Self-Management and Diabetes Health.

Dr. Polonsky’s recent research has focused on topics including quality of life in diabetes, diabetes-related distress and depression, hypoglycemic fear, blood glucose monitoring behavior and attitudes in people living with diabetes, group-based behavior change programs, and emotional and behavioral responses to the diagnosis of diabetes.

Hope Warshaw, MMSc, RD, CDE, BC-ADM, has been a dietitian and diabetes educator for nearly thirty-five years. She has owned her consulting practice, Hope Warshaw Associates, LLC, for the last twenty-five years. Her work today spans from corporate consulting to consumer and professional writing and individual diabetes and weight management counseling provided in-person or virtually. She’s also a Certified Pump Trainer.

Warshaw has authored professional articles in Diabetes Care, The Diabetes Educator, AADE in Practice and others. She’s the co-author of several books for healthcare professionals published by ADA including: Practical Carbohydrate Counting: A How-to-Teach Guide for Health Professionals. She’s authored numerous consumer books for ADA including Diabetes Meal Planning Made Easy and Guide to Healthier Restaurant Eating. She’s a freelance writer and the contributing editor for Diabetic Living magazine and website and writes a monthly Nutrition Q&A column for The Washington Post. Warshaw has been an active volunteer with diabetes and nutrition-related organizations and efforts locally and nationally.

Among diabetes educators, Warshaw has been a leading promoter of the Diabetes Online Community and the value it brings to people with diabetes and their caregivers.

Dr. Peter Kash is Executive Chairman of Time Flash. He was a co-founder and partner of Two River Group and President of Riverbank Capital Securities specializing in creating and financing biopharmaceutical companies. He has co-founded more than a dozen biotech companies and served on numerous boards  including  Keryx Biopharmaceuticals, Velcera and Intercept Pharmaceuticals.

Dr. Kash has worked on Wall Street for 30 years. From 1990-1992 he was an Associate Professor of Marketing at Polytechnic University.  During 1996-2000 he was an Adjunct Professor of Entrepreneurship at the Wharton Business School. During 2000-2002 he was a Visiting Professor of Entrepreneurship at the Graduate School of Business at Nihon University in Tokyo. He holds a BS in Management Science from SUNY Binghamton, MBA from Pace University and a Doctorate in Education from the Azrieli Graduate School of Yeshiva University. He is also an author of several books on business and healthcare.